Oxygen is life!

Welcome to Oxyven

Oxyven – our company

The Oxyven-Device Dr. H.S. Regelsberger GmbH & Co. KG was founded in the year 1975. Dr. med. Regelsberger (neurologist/neurosurgeon from Detmold) has done intensive research on intravenous application of minute amounts of oxygen and has been able to determine its therapeutic effect. Thus, it became his great desire to standardize the implementation of this particular application with its sophisticated device. We have been developing and manufacturing medical devices ever since. They apply safe and exact amounts of oxygen into the veins.

Application methods have been developed in continuous stages to make the safety related highly sophisticated

oxygen-application device available. It is dose dependable and best suitable for flow–monitoring intravenous oxygen-insufflation in the medicine sector. Optimum support for our customers in the supervision of the practical application of this specific application device in practice is of particular importance to us. In this specific way, the customers receive a detailed instruction in their practice.

This specified therapy founded by Dr. med. Regelsberger has been implemented by over 1000 therapists - according to details of the international society for oxygen-nierungstherapie e.V. (www.oxyvenierung.com).

Applimed O² 1000

The intravenous oxygen application

You can get indications and details to the thirty year research development in the therapy method of the intravenous oxygen-application carried out by Dr. med. H.S. Regelsberger in

would you please inform yourself in the appropriate regulations, panels or by the International Society of Oxyvenierungstherapie e.V.
www.oxyvenierung.com

Applimed-O2 1000 controls the exact and reliable application of medical oxygen in the intravenous method in a dosage in a range between 1 to 2ml/min. Oxygen is a very important component in complementary medicine.

Oxygen leads to the intensified formation of the blood flow and antithrombotic hormone Prostacyclin. It is formed in the lung endothelium. Result is a strong vascular dilation in the complete body structure (an average increase of Prostacycline of more than 800%; according to an article written by Prof. Dr. J.C. Frölich - Hannover Medical School).

An eosinophilia is initiated by applying oxygen. The eosinophilic granulocytes are capable of forming the 15-lipoxygenase-1, with oxygen release from the arachidonic acid cascade. The leukotriene synthesis is being blocked by this process. The anti-inflammatory effect has been confirmed by the work of Prof. Dr. sc. Med. Hartmut Kühn - Charite Berlin. Further literature is available through our: Contact.

Exhibitions and seminars 2017


January 2017

13.01. - 14.01.

NieCo 2017
5. Niederrhein-Congress für Komplementärmedizin

Program (pdf)


February 2017

11.02.

Seminar
Informations on request

please refer: http://www.cfb-eigenherstellung.de

Registration (pdf)


March 2017

04.03.

Zertifizierungskurs für Oxyvenierung
Mehr Sicherheit durch ein besseres Verständnis

Registration (pdf)

11.03. - 12.03.

Sanum – Therapie-Seminar
Hannover

Program (pdf)

25.03. - 26.03.

Chelat – Kompakt-Seminar
Bremen

Program/Registration (pdf)


April 2017

29.04.

CAM – Kongress Düsseldorf

please refer: http://www.cam-expo.eu


May 2017

06.05. - 07.05.

Kongress für komplementäre Krebstherapie
München

Program/Registration (pdf)

13.05. - 14.05.

Internationale Gesellschaft für Oxyvenierung e.V.
in Kassel/Ramada Hotel

please refer: http://www.oxyvenierung.com

Program/Registration (pdf)

23.05. - 30.05.

Auslandsseminar Madeira
Bio-Diagnostik

Program/Registration (pdf)


June 2017

09.06. - 10.06.

12. Internationaler ISLA Kongress für Medizinische Laseranwendungen
Beverungen

please refer: http://www.isla-laser.org

Program/Registration (pdf)


July 2017

01.07. - 02.07.

4. AGMID Kongress
Biotop Mensch: Mikrobiom Update – Diagnostik & Therapie
München-Unterhaching

Program/Registration (pdf)

08.07.

Heilpraktikerkongress des Südens 2017
MOC Veranstaltungscenter München

please refer: http://www.bdhn.de/kongress.html


September 2017

01.09. - 02.09.

Das Paracelsus-Erfolgskonzept

please refer: https://www.paracelsus.ch/academy

09.09. - 10.10.

Mesotherapie – Einführungskurs
München

please refer: https://www.mesotherapie.org/therapeuten-kurse/

16.09. - 17.09.

1. Symposium für autonome Funktionsdiagnostik und Regulationsmedizin
Bad Kissingen

please refer: http://www.igafev.com

Program/Registration (pdf)

30.09. - 01.10.

INNOVEUTIKA
Kongress für innovative komplementäre Heilkunde
Congresshalle Saarbrücken

please refer: http://www.innoveutika.de

Program (pdf)

30.09. - 01.10.

6. Humanmedizinische Tage Bingen
Molekulare Organ- und Immuntherapie
Bingen

Program/Registration (pdf)


October

13.10. - 14.10.

Let´s work Wissenschaftspark
Gelsenkirchen
Mit Vortrag von HP Stefan Marzinowski

Program/Registration (pdf)

28.10.

Zertifizierungskurs Oxyvenierung
Baden-Baden

Program/Registration (pdf)

28.10. - 01.11.

Medizinische Woche
Baden-Baden

please refer: http://www.medwoche.de


November

18.11. - 19.11.

Chelat-Kompakt-Seminar

Program/Registration (pdf)

18.11.

Chelat-Seminar
München

please refer: http://www.praxis-thust.de/seminare.html

24.11. - 25.11.

Biologische Krebstherapie, integrativ

please refer: https://www.paracelsus.ch/academy/detail?sid=13

Contact

Should you need further information to our oxygen-application and to our oxyven therapy according to Dr. med. Regelsberger. – Just leave us a message; we will enjoy supporting you.

Oxyven-Geräte
Dr. med. H.S. Regelsberger GmbH & Co. KG

Brookstr. 31 A
D-49811 Lingen

Telephone: +49 (0) 591 / 901 108-0
Fax: +49 (0) 591 / 901 108-20

E-Mail: info@oxyven.de

* required fields